Expression patterns and prognostic relevance of subtype‐specific transcription factors in surgically resected small‐cell lung cancer: an international multicenter study
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Expression patterns and prognostic relevance of subtype‐specific transcription factors in surgically resected small‐cell lung cancer: an international multicenter study
Authors
Keywords
-
Journal
JOURNAL OF PATHOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2022-05-01
DOI
10.1002/path.5922
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prognostic Implications of Molecular Subtypes in Primary Small Cell Lung Cancer and Their Correlation With Cancer Immunity
- (2022) Jing Qi et al. Frontiers in Oncology
- Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities
- (2021) Carl M. Gay et al. CANCER CELL
- SMARCA4 (BRG1) and SMARCB1 (INI1) expression in TTF-1 negative neuroendocrine carcinomas including merkel cell carcinoma
- (2021) Jatin S. Gandhi et al. PATHOLOGY RESEARCH AND PRACTICE
- Capitalizing on Synthetic Lethality of MYC to Treat Cancer in the Digital Age
- (2021) Dexter Kai Hao Thng et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Small-cell lung cancer
- (2021) Charles M. Rudin et al. Nature Reviews Disease Primers
- Molecular profiles of small cell lung cancer subtypes: therapeutic implications
- (2021) Anna Schwendenwein et al. Molecular Therapy-Oncolytics
- Molecular Subtypes of Primary Small Cell Lung Cancer Tumors and Their Associations with Neuroendocrine and Therapeutic Markers
- (2021) Song Qu et al. Journal of Thoracic Oncology
- MYC Drives Temporal Evolution of Small Cell Lung Cancer Subtypes by Reprogramming Neuroendocrine Fate
- (2020) Abbie S. Ireland et al. CANCER CELL
- Molecular subtypes and clinical outcomes to initial systemic treatment in patients with small cell lung cancer.
- (2020) Wei-Chu Victoria Lai et al. JOURNAL OF CLINICAL ONCOLOGY
- Neuroendocrine subtypes of small cell lung cancer differ in terms of immune microenvironment and checkpoint molecule distribution
- (2020) David Dora et al. Molecular Oncology
- Advances in Small-Cell Lung Cancer (SCLC) Translational Research
- (2020) Benjamin J. Drapkin et al. Cold Spring Harbor Perspectives in Medicine
- Small Cell Lung Carcinoma Subtypes Defined by ASCL1, NEUROD1, POU2F3 and YAP1: Comprehensive Immunohistochemical and Histopathologic Characterization
- (2020) Marina K. Baine et al. Journal of Thoracic Oncology
- Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors
- (2020) Rilan Bai et al. Biomarker Research
- Proteomic Workflows for High-Quality Quantitative Proteome and Post-Translational Modification Analysis of Clinically Relevant Samples from Formalin-Fixed Paraffin-Embedded Archives
- (2020) Magdalena Kuras et al. JOURNAL OF PROTEOME RESEARCH
- Analysis of DLL3 and ASCL1 in Surgically Resected Small Cell Lung Cancer (HOT1702)
- (2019) Megumi Furuta et al. ONCOLOGIST
- Subtype-specific secretomic characterization of pulmonary neuroendocrine tumor cells
- (2019) Xu-Dong Wang et al. Nature Communications
- POU2F3 is a master regulator of a tuft cell-like variant of small cell lung cancer
- (2018) Yu-Han Huang et al. GENES & DEVELOPMENT
- Differential Proteomic Analysis between Small Cell Lung Carcinoma (SCLC) and Pulmonary Carcinoid Tumors Reveals Molecular Signatures for Malignancy in Lung Cancer
- (2018) Kiyonaga Fujii et al. Proteomics Clinical Applications
- Immunohistochemistry for small cell carcinoma: a potential diagnostic pitfall
- (2018) William A Wallace et al. HISTOPATHOLOGY
- NCCN Guidelines Insights: Small Cell Lung Cancer, Version 2.2018
- (2018) Gregory P. Kalemkerian et al. Journal of the National Comprehensive Cancer Network
- Immunohistochemistry on old archival paraffin blocks: is there an expiry date?
- (2017) Federica Grillo et al. JOURNAL OF CLINICAL PATHOLOGY
- The Use of Immunohistochemistry Improves the Diagnosis of Small Cell Lung Cancer and Its Differential Diagnosis. An International Reproducibility Study in a Demanding Set of Cases
- (2017) Erik Thunnissen et al. Journal of Thoracic Oncology
- Reciprocal expression of INSM1 and YAP1 defines subgroups in small cell lung cancer
- (2017) Karen McColl et al. Oncotarget
- The role of surgery in high grade neuroendocrine tumours of the lung
- (2017) Stefan Welter et al. Journal of Thoracic Disease
- Loss ofYAP1defines neuroendocrine differentiation of lung tumors
- (2016) Takeshi Ito et al. CANCER SCIENCE
- SCLC–State of the Art and What Does the Future Have in Store?
- (2016) Kathrin Kahnert et al. Clinical Lung Cancer
- Predictive biomarkers for checkpoint inhibitor-based immunotherapy
- (2016) Geoffrey T Gibney et al. LANCET ONCOLOGY
- ASCL1 and NEUROD1 Reveal Heterogeneity in Pulmonary Neuroendocrine Tumors and Regulate Distinct Genetic Programs
- (2016) Mark D. Borromeo et al. Cell Reports
- Comprehensive genomic profiles of small cell lung cancer
- (2015) Julie George et al. NATURE
- A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo
- (2015) Laura R. Saunders et al. Science Translational Medicine
- Ki-67 Antigen in Lung Neuroendocrine Tumors: Unraveling a Role in Clinical Practice
- (2014) Giuseppe Pelosi et al. Journal of Thoracic Oncology
- Archived Formalin-Fixed Paraffin-Embedded (FFPE) Blocks: A Valuable Underexploited Resource for Extraction of DNA, RNA, and Protein
- (2013) Theresa J. Kokkat et al. BIOPRESERVATION AND BIOBANKING
- ASCL1 and RET expression defines a clinically relevant subgroup of lung adenocarcinoma characterized by neuroendocrine differentiation
- (2013) F Kosari et al. ONCOGENE
- Update on small cell carcinoma and its differentiation from squamous cell carcinoma and other non-small cell carcinomas
- (2012) William D Travis MODERN PATHOLOGY
- Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1
- (2012) Lauren Averett Byers et al. Cancer Discovery
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started